Huma is a global health tech company that focuses on transforming healthcare and research through innovative digital solutions. The company operates in the healthcare and life sciences sectors, partnering with scientists, technologists, healthcare providers, and life sciences professionals. Huma's core offerings include digital phenotyping, remote patient care, and decentralized clinical trials. The company serves a diverse range of clients, including patients with chronic conditions such as Type 2 Diabetes and Pulmonary Arterial Hypertension, as well as those undergoing procedures like Total Knee Replacement surgery. Huma's business model revolves around providing intelligent software solutions that enable continuous and remote patient monitoring, thereby facilitating proactive rather than reactive medical care. The company generates revenue through partnerships with healthcare providers, research organizations, and universities, offering services that include virtual clinical trials, real-world evidence collection, and digital biomarkers. Huma's platform is designed to collect and analyze patient-generated data in real-time, supporting better clinical care and research outcomes.

Keywords: digital phenotyping, remote care, decentralized trials, chronic care, virtual clinical trials, real-world evidence, digital biomarkers, patient monitoring, healthcare partnerships, life sciences.